BackImmatics N.V - Warrants (01/07/2025) Overview

Immatics N.V - Warrants (01/07/2025) Total Revenue

Immatics N.V - Warrants (01/07/2025)'s total revenue is $42M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$9.30M
↑ 96.23% YoY

As of Jun 2026

Annual Revenue (TTM)

$41.80M
↓ 67.88% YoY

Trailing 12 months ending Jun 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Immatics N.V - Warrants (01/07/2025) (IMTXW) FAQ

The latest total revenue for IMTXW is $42M as of June 2026. That compares with $130M in the prior-year period — down 67.9% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Immatics N.V - Warrants (01/07/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IMTXW's total revenue moved from $130M to $42M — a 67.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immatics N.V - Warrants (01/07/2025)'s operating scale or balance-sheet position.

Against Healthcare companies, IMTXW currently prints $42M for total revenue, while the sector average sits near $110B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Immatics N.V - Warrants (01/07/2025)'s growth, margins, and balance sheet.

A total revenue figure of $42M for IMTXW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting IMTXW's total revenue ($42M), review year-over-year change from $130M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.